|
|
|
|
||
Re: Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell TrialsSRNE should see a decent cash distribution from Celularity's IPO, I'm guessing at least $50ML ?? More importantly, liquidity will now be there if Ji decides to unload SRNE's remaining interest post-IPO, cheers |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
937 | Re: Celularity Gains FDA Orphan Drug Status on Strength of Placental Stem Cell Trials | DonPA | 0 | 4/14/2021 8:05:31 PM |